17.13 — Epidemics and Pandemics

In 1854, London's Broad Street had a cholera outbreak that killed over 600 people in a few weeks. John Snow mapped the deaths, found they clustered around one water pump, and had the handle removed.

He did not know what caused cholera — the bacterium would not be identified for another thirty years. He did not need to. The pattern was enough.

Epidemiology is the science of finding causes from patterns, and it works without knowing the mechanism. That is why it is powerful, and why it produced results long before microbiology existed.

The vocabulary

Endemic — constantly present in a population at a baseline level. Malaria in much of Africa; chickenpox before vaccination.

Outbreak — more cases than expected, in a defined place and time.

Epidemic — a larger outbreak, spreading.

Pandemic — an epidemic across multiple countries or continents.

And "endemic" does not mean mild or harmless, which is a widespread misunderstanding. Malaria is endemic and kills 600,000 people a year. Endemic means stable, not safe.

What determines spread

R₀ — the basic reproduction number. The average number of people one infected person infects in a fully susceptible population.

Above 1, the epidemic grows. Below 1, it dies out.

Disease	R₀
Measles	12–18
Pertussis	12–17
Chickenpox	10–12
Polio, smallpox	5–7
COVID-19 (original)	2–3
Influenza (seasonal)	1.2–1.4
Ebola	1.5–2.5

And R₀ is not a fixed property of the pathogen. It depends on contact patterns, population density and behaviour, which is why the same virus produces different numbers in different settings.

Rₜ — the effective reproduction number — is R₀ adjusted for immunity and interventions, and it is what is actually tracked during an outbreak.

The herd immunity threshold follows directly (Chapter 13.5):

1 - \frac{1}{R_0}

Which is why measles needs around 95 percent coverage and is always the first disease to return when coverage falls.

Other factors that matter as much as R₀:

The incubation period. A long one — HIV — allows silent spread. A short one — influenza — makes outbreaks explosive and easier to trace.

Whether transmission occurs before symptoms. This is the single most consequential variable for control.

SARS in 2003 transmitted only after symptoms appeared, so isolating symptomatic people worked, and it was contained. COVID-19 transmitted substantially before symptoms and from people who never developed any, which is exactly why the same approach failed.

Case fatality rate, and the counter-intuitive point: a highly lethal pathogen frequently spreads less, because it incapacitates or kills its host before they can transmit widely. Ebola's high lethality is part of why it has produced outbreaks rather than pandemics.

Superspreading. Transmission is usually not evenly distributed. The "20/80 rule" — around 20 percent of cases causing around 80 percent of transmission — holds for many pathogens.

Which has a practical consequence: if transmission is driven by rare high-transmission events, then targeting those settings — crowded, indoor, poorly ventilated, prolonged contact — is more efficient than uniform restrictions.

The historic pandemics, briefly

Plague — the Justinian plague in the 540s, the Black Death of 1347 to 1351 which killed perhaps a third of Europe, and a third pandemic beginning in the 1850s. Caused by Yersinia pestis, spread by fleas on rats and — in the pneumonic form — person to person. It still occurs and is treatable with antibiotics.

1918 influenza — an estimated 50 million deaths, more than the First World War. Unusually, it killed healthy young adults disproportionately, possibly through an excessive immune response.

And it was not Spanish. It was called Spanish flu because Spain was neutral and its press was not censored, so its reports were the ones that circulated — an early lesson in how outbreak information is shaped by who is allowed to publish.

HIV/AIDS — over 40 million deaths, and ongoing (Chapter 17.9).

COVID-19 — an estimated 7 million confirmed deaths and excess mortality estimates of 15 to 20 million.

What COVID-19 taught

And it is worth recording honestly, including the mistakes, because the next one will test the same systems.

What worked:

Vaccine development at unprecedented speed. From genome sequence to authorised vaccine in under a year, built on decades of prior mRNA research (Chapter 13.5).

Global genomic surveillance. Millions of sequences shared openly, allowing variants to be tracked in near real time — a capability that did not exist before.

Large randomised trials embedded in routine care. The RECOVERY trial found that dexamethasone reduced deaths in ventilated patients, and that hydroxychloroquine and several other candidates did not. A cheap old steroid saved an estimated million lives, and it was found because a trial was run rather than because the drug was plausible.

Recognising airborne transmission, eventually, and the consequent focus on ventilation (Chapter 17.4).

What did not:

Slow initial recognition of asymptomatic and pre-symptomatic transmission, which invalidated the containment strategy that had worked for SARS.

Slow acceptance of aerosol transmission, which delayed ventilation advice by many months.

Inequitable vaccine distribution. High-income countries had substantial coverage before many low-income countries had begun, which was both an ethical failure and an epidemiological one, since uncontrolled transmission anywhere generates variants everywhere.

Inconsistent communication, which eroded trust — particularly where guidance changed without explaining why it had changed. Evidence changing is normal; presenting each change as a certainty made each revision look like a failure.

Neglect of indirect harms — disrupted cancer diagnosis, immunisation, tuberculosis and HIV programmes, education, and mental health.

And the misinformation environment, which was itself an epidemiological factor rather than a side issue.

Preparing

Surveillance — including wastewater monitoring, which detects circulating pathogens at population level without testing individuals and which proved genuinely useful.

Rapid diagnostic and vaccine platforms. The "100 days mission" — a target of having a vaccine within 100 days of identifying a new threat — is now an explicit international goal, and it is plausible given what mRNA and viral vector platforms demonstrated.

Stockpiles and manufacturing capacity, distributed rather than concentrated.

Health system resilience — spare capacity, which is expensive and is exactly what efficiency drives out.

One Health — recognising that most emerging infections are zoonotic (Chapter 17.4), so surveillance at the human–animal interface, and attention to land use change, wildlife trade and intensive farming, are outbreak prevention.

And equity, as a practical measure rather than a moral one. A pathogen circulating anywhere threatens everywhere, which is the argument that self-interest and fairness point the same way.

What raises the risk

Population growth and density.Land use change bringing people into contact with wildlife.Intensive animal farming.Global travel — a pathogen can circle the planet in 36 hours. Climate change, extending the range of vectors (Chapter 17.7). Antimicrobial resistance (Chapter 17.12). And conflict and displacement, which break down every system that would otherwise contain an outbreak.

What individuals can do

Vaccination, including keeping up with boosters offered.

Staying home when infectious.

Ventilating indoor spaces.

Hand hygiene.

And thinking carefully about information sources — which is a genuine health behaviour rather than an aside. Volume VI covers how to evaluate a claim.

Ending Part 17 where it should end

The record of the last century in infectious disease is the strongest argument for medicine and public health that exists.

Smallpox eradicated. Polio reduced by over 99 percent. Guinea worm nearly gone.

Child deaths from diarrhoea down over 90 percent. Measles deaths down over 80 percent since 2000.

HIV from a death sentence to one tablet a day. Hepatitis C from incurable to cured in eight weeks. Tuberculosis curable, and drug-resistant tuberculosis now curable in six months of oral drugs.

Global life expectancy has risen from around 46 in 1950 to over 73 today, and infectious disease control is the largest single contributor.

None of it happened by itself. It came from clean water, sanitation, vaccination, antibiotics, refrigeration, surveillance, and the unglamorous work of people who counted things carefully.

And the remaining problems — resistance, inequity, emerging pathogens — are problems of delivery, cooperation and stewardship rather than of missing knowledge.

Which is a much better position to be in than the alternative.

What Part 18 does next

Infection has been pushed back far enough that the leading causes of death in most of the world are now something else entirely.

Part 18 covers them: heart disease, stroke, diabetes and their relatives — the conditions that arise from a Pleistocene body living in a world of abundant calories and minimal physical demand (Chapter 3.6), and which are, to an unusual degree, preventable.